{"date":"2026-01-09","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6976-2026-01-09-1909-1vb0kud","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2026-01-09","time":"19:09:00","subject":"本公司代重要子公司Acepodia Biotechnologies, Ltd.宣布與百奧賽圖（北京）醫藥科技股份有限公司（Biocytogen）達成選擇權與授權合約，共同開發同類首創雙特異性抗體雙藥物複合體","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2026-01-09 19:09，「本公司代重要子公司Acepodia Biotechnologies, Ltd.宣布與百奧賽圖（北京）醫藥科技股份有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-01-09-1812-vtaj68","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-01-09","time":"18:12:27","subject":"公告本公司國際策略長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-01-09 18:12，「公告本公司國際策略長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2026-01-09-1812-zct0lq","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2026-01-09","time":"18:12:09","subject":"公告本公司副董事長異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2026-01-09 18:12，「公告本公司副董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-01-09-1807-10os6p6","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-01-09","time":"18:07:45","subject":"補充公告本公司董事會決議通過投資有價證券","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-01-09 18:07，「補充公告本公司董事會決議通過投資有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2026-01-09-1756-ois9r3","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2026-01-09","time":"17:56:28","subject":"公告本公司初次申請股票創新板上市時所出具之承諾事項暨其後續執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2026-01-09 17:56，「公告本公司初次申請股票創新板上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-01-09-1602-16g7qjx","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-01-09","time":"16:02:48","subject":"公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形","clause":"第51款","fact_date":"2026-01-09","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-01-09 16:02，「公告本公司初次申請股票上市時所出具之承諾事項暨其後續執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2026-01-09-1555-1hkj5dk","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2026-01-09","time":"15:55:30","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-01-09","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2026-01-09 15:55，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-01-09-1550-1x5hv7m","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-01-09","time":"15:50:09","subject":"公告本公司115年第一次現金增資發行新股認股基準日及相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-01-09 15:50，「公告本公司115年第一次現金增資發行新股認股基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-01-09-1540-d89zp1","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-01-09","time":"15:40:08","subject":"公告本公司「局部麻醉劑-黏土複合組合物」取得澳洲發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-01-09 15:40，「公告本公司「局部麻醉劑-黏土複合組合物」取得澳洲發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2026-01-09-1516-1lguwlo","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2026-01-09","time":"15:16:06","subject":"公告本公司現金增資委託代收價款及存儲專戶機構","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：因華（4172），2026-01-09 15:16，「公告本公司現金增資委託代收價款及存儲專戶機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2026-01-09-1502-lnj9s3","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2026-01-09","time":"15:02:58","subject":"公告本公司初次申請股票上市時所出具之承諾事項執行情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2026-01-09 15:02，「公告本公司初次申請股票上市時所出具之承諾事項執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}